Breaking News Instant updates and real-time market news.

ALXN

Alexion

$123.32 /

+6.13 (+5.23%)

, APRE

Aprea Therapeutics

$21.90 /

+0.11 (+0.50%)

09:07
11/05/20
11/05
09:07
11/05/20
09:07

Morgan Stanley to hold a virtual bus tour

2020 Biotech Virtual Bus Tour to be held on November 4-5.

ALXN

Alexion

$123.32 /

+6.13 (+5.23%)

APRE

Aprea Therapeutics

$21.90 /

+0.11 (+0.50%)

ARGX

Argenx

$274.97 /

+16.97 (+6.58%)

FRLN

Freeline

$17.30 /

-0.48 (-2.70%)

FULC

Fulcrum Therapeutics

$12.05 /

+0.85 (+7.59%)

IMRA

Imara

$16.70 /

+0.1 (+0.60%)

KPTI

Karyopharm

$15.19 /

+0.98 (+6.90%)

KYMR

Kymera Therapeutics

$40.28 /

+3.73 (+10.21%)

MRNA

Moderna

$69.71 /

+0.71 (+1.03%)

PAND

Pandion Therapeutics

$13.06 /

+0.12 (+0.93%)

RDUS

Radius Health

$13.75 /

+0.5 (+3.77%)

RPTX

Repare Therapeutics

$27.75 /

+0.52 (+1.91%)

  • 05

    Nov

  • 05

    Nov

  • 05

    Nov

  • 05

    Nov

  • 09

    Nov

  • 10

    Nov

  • 12

    Nov

  • 18

    Nov

  • 20

    Nov

  • 05

    Dec

  • 19

    Mar

  • 07

    Nov

  • 12

    Feb

  • 04

    Mar

  • 12

    Mar

  • 19

    May

  • 28

    May

  • 19

    Jun

  • 17

    Jul

  • 07

    Aug

  • 21

    Aug

ALXN Alexion
$123.32 /

+6.13 (+5.23%)

11/05/20 Citi
Alexion price target raised to $157 from $145 at Citi
10/30/20 SVB Leerink
Alexion price target raised to $163 from $159 at SVB Leerink
10/29/20 Piper Sandler
Alexion price target raised to $179 from $175 at Piper Sandler
10/28/20 UBS
Alexion initiated with a Neutral at UBS
APRE Aprea Therapeutics
$21.90 /

+0.11 (+0.50%)

11/02/20 Baird
Aprea Therapeutics designated a Fresh Pick at Baird
09/29/20 JPMorgan
Aprea Therapeutics resumed with a Neutral at JPMorgan
06/22/20
Fly Intel: Top five analyst initiations
06/22/20 H.C. Wainwright
Aprea Therapeutics initiated with a Neutral at H.C. Wainwright
ARGX Argenx
$274.97 /

+16.97 (+6.58%)

10/29/20 JPMorgan
Argenx price target raised to EUR 240 from EUR 220 at JPMorgan
10/23/20 Barclays
Argenx price target lowered to EUR 215 from EUR 225 at Barclays
10/23/20 H.C. Wainwright
Argenx price target lowered to $265 from $272 at H.C. Wainwright
10/13/20 Barclays
Argenx price target raised to EUR 225 from EUR 195 at Barclays
FRLN Freeline
$17.30 /

-0.48 (-2.70%)

09/01/20 Evercore ISI
Freeline initiated with an Outperform at Evercore ISI
09/01/20 Wedbush
Wedbush bullish on Freeline, initiates with an Outperform
09/01/20 Wedbush
Freeline initiated with an Outperform at Wedbush
09/01/20 Morgan Stanley
Freeline initiated with an Overweight at Morgan Stanley
FULC Fulcrum Therapeutics
$12.05 /

+0.85 (+7.59%)

10/15/20 Piper Sandler
Fulcrum Therapeutics initiated with an Overweight at Piper Sandler
08/12/20
Fly Intel: Top five analyst downgrades
08/12/20 BTIG
Fulcrum Therapeutics price target lowered to $22 from $27 at BTIG
08/12/20 Morgan Stanley
Fulcrum Therapeutics downgraded at Morgan Stanley, price target slashed to $11
IMRA Imara
$16.70 /

+0.1 (+0.60%)

08/17/20
Fly Intel: Top five analyst upgrades
08/17/20 Citi
Imara upgraded to Buy from Neutral at Citi
06/30/20 Citi
Imara downgraded to Neutral from Buy at Citi
04/07/20 Citi
Imara initiated with a Buy at Citi
KPTI Karyopharm
$15.19 /

+0.98 (+6.90%)

09/25/20 RBC Capital
Karyopharm shares undervalued as seli moves into MF, says RBC Capital
07/01/20 Morgan Stanley
Karyopharm initiated with an Overweight at Morgan Stanley
06/23/20 JPMorgan
Karyopharm price target raised to $37 from $31 at JPMorgan
06/23/20 RBC Capital
Karyopharm price target raised to $30 from $28 at RBC Capital
KYMR Kymera Therapeutics
$40.28 /

+3.73 (+10.21%)

09/15/20 Morgan Stanley
Kymera Therapeutics initiated with an Equal Weight at Morgan Stanley
09/15/20 Cowen
Cowen starts Kymera at Outperform, sees platform positioned for success
09/15/20 Guggenheim
Kymera Therapeutics initiated with a Buy at Guggenheim
09/15/20 BofA
Kymera Therapeutics initiated with a Neutral at BofA
MRNA Moderna
$69.71 /

+0.71 (+1.03%)

10/08/20 Piper Sandler
Moderna regains rights to adult RSV vaccine mRNA-1172, Piper ups target to $136
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
09/18/20 Needham
Moderna shares attractive long term on mRNA platform and pipeline, says Needham
09/17/20 Jefferies
Moderna COVID trial stats suggest late Oct. or Nov. for data, says Jefferies
PAND Pandion Therapeutics
$13.06 /

+0.12 (+0.93%)

08/11/20
Fly Intel: Top five analyst initiations
08/11/20 Morgan Stanley
Pandion Therapeutics initiated with an Overweight at Morgan Stanley
08/11/20 SVB Leerink
SVB Leerink bullish on Pandion Therapeutics, initiates with an Outperform
08/11/20 SVB Leerink
Pandion Therapeutics initiated with an Outperform at SVB Leerink
RDUS Radius Health
$13.75 /

+0.5 (+3.77%)

10/22/20 H.C. Wainwright
Radius Health price target lowered to $22 from $28 at H.C. Wainwright
09/29/20 JPMorgan
Radius Health resumed with a Neutral at JPMorgan
08/11/20 Jefferies
Radius Health price target lowered to $14 from $17 at Jefferies
07/08/20 SVB Leerink
Radius Health downgraded to Market Perform from Outperform at SVB Leerink
RPTX Repare Therapeutics
$27.75 /

+0.52 (+1.91%)

10/28/20
Fly Intel: Top five analyst initiations
10/28/20 Northland
Repare Therapeutics initiated with an Outperform at Northland
09/25/20 Piper Sandler
Repare Therapeutics viewed as core long-term holding at Piper Sandler
07/14/20
Fly Intel: Top five analyst initiations

TODAY'S FREE FLY STORIES

Conference/Events
Upland Software management to meet virtually with Truist » 04:55
06/15/21
06/15
04:55
06/15/21
04:55
UPLD

Upland Software

$41.74 /

-0.07 (-0.17%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UPLD Upland Software
$41.74 /

-0.07 (-0.17%)

UPLD Upland Software
$41.74 /

-0.07 (-0.17%)

05/18/21 Jefferies
Upland Software price target lowered to $50 from $58 at Jefferies
03/29/21 Credit Suisse
Upland Software assumed with an Outperform at Credit Suisse
03/03/21 Truist
Upland Software price target raised to $65 from $60 at Truist
02/25/21 Craig-Hallum
Upland Software price target raised to $64 from $29 at Craig-Hallum
UPLD Upland Software
$41.74 /

-0.07 (-0.17%)

  • 12
    Aug
Conference/Events
Viracta Therapeutics management to meet virtually with Oppenheimer » 04:55
06/15/21
06/15
04:55
06/15/21
04:55
VIRX

Viracta Therapeutics

$13.03 /

+1.14 (+9.59%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VIRX Viracta Therapeutics
$13.03 /

+1.14 (+9.59%)

VIRX Viracta Therapeutics
$13.03 /

+1.14 (+9.59%)

05/03/21 H.C. Wainwright
Viracta Therapeutics initiated with a Buy at H.C. Wainwright
04/26/21 SVB Leerink
SVB Leerink bullish on Viracta Therapeutics, initiates with an Outperform
04/26/21 SVB Leerink
Viracta Therapeutics initiated with an Outperform at SVB Leerink
03/25/21
Fly Intel: Top five analyst initiations
VIRX Viracta Therapeutics
$13.03 /

+1.14 (+9.59%)

Conference/Events
Mizuho healthcare analysts to hold an analyst/industry conference call » 04:55
06/15/21
06/15
04:55
06/15/21
04:55

Healthcare Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Take-Two participates in a conference call with Truist » 04:55
06/15/21
06/15
04:55
06/15/21
04:55
TTWO

Take-Two

$186.72 /

+0.44 (+0.24%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TTWO Take-Two
$186.72 /

+0.44 (+0.24%)

TTWO Take-Two
$186.72 /

+0.44 (+0.24%)

06/03/21
Fly Intel: Top five analyst upgrades
06/03/21 Jefferies
Jefferies upgrades Take-Two to Buy, 'more confident than ever' in long-term view
06/03/21 Jefferies
Take-Two upgraded to Buy from Hold at Jefferies
06/02/21 Stifel
Take-Two's Nordeus acquisition bolsters presence in mobile, says Stifel
TTWO Take-Two
$186.72 /

+0.44 (+0.24%)

TTWO Take-Two
$186.72 /

+0.44 (+0.24%)

TTWO Take-Two
$186.72 /

+0.44 (+0.24%)

TTWO Take-Two
$186.72 /

+0.44 (+0.24%)

Conference/Events
Luminar to host a virtual event » 04:55
06/15/21
06/15
04:55
06/15/21
04:55
LAZR

Luminar

$23.98 /

+0.44 (+1.87%)

CEO & Founder Austin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LAZR Luminar
$23.98 /

+0.44 (+1.87%)

LAZR Luminar
$23.98 /

+0.44 (+1.87%)

05/25/21 Berenberg
Luminar initiated with a Hold at Berenberg
04/20/21 BofA
Luminar initiated with a Neutral at BofA
04/20/21 BofA
Luminar initiated with a Neutral at BofA
03/24/21 UBS
Apple recently granted patent for LiDAR system, says UBS
LAZR Luminar
$23.98 /

+0.44 (+1.87%)

LAZR Luminar
$23.98 /

+0.44 (+1.87%)

LAZR Luminar
$23.98 /

+0.44 (+1.87%)

LAZR Luminar
$23.98 /

+0.44 (+1.87%)

Hot Stocks
Callaway Golf to replace GrubHub in the S&P 400 at open on 6/15 » 04:55
06/15/21
06/15
04:55
06/15/21
04:55
ELY

Callaway Golf

$34.51 /

+0.17 (+0.50%)

, GRUB

GrubHub

$18.80 /

+0.27 (+1.46%)

, TKAYY

Just Eat Takeaway.com

$10.47 /

+ (+0.00%)

Callaway Golf Co. (ELY)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ELY Callaway Golf
$34.51 /

+0.17 (+0.50%)

GRUB GrubHub
$18.80 /

+0.27 (+1.46%)

TKAYY Just Eat Takeaway.com
$10.47 /

+ (+0.00%)

ELY Callaway Golf
$34.51 /

+0.17 (+0.50%)

05/20/21 Roth Capital
Callaway Golf price target raised to $41 from $34 at Roth Capital
05/11/21 B. Riley
Callaway Golf price target raised to $38 from $35 at B. Riley
04/14/21 B. Riley
B. Riley reiterates $35 target on Callaway after Master's tournament
04/07/21 Roth Capital
Callaway Golf price target raised to $34 from $26 at Roth Capital
GRUB GrubHub
$18.80 /

+0.27 (+1.46%)

05/11/21 Exane BNP Paribas
GrubHub upgraded to Neutral from Underperform at Exane BNP Paribas
05/05/21 Cowen
Department of Labor comments incrementally encouraging for Uber/Lyft, says Cowen
01/04/21 Barclays
GrubHub assumed with an Equal Weight at Barclays
10/16/20 HSBC
HSBC upgrades Just Eat Takeaway.com to Buy on continued execution
TKAYY Just Eat Takeaway.com
$10.47 /

+ (+0.00%)

05/17/21 JPMorgan
Just Eat Takeaway.com price target lowered to 9,676 GBp at JPMorgan
05/11/21 Exane BNP Paribas
Just Eat Takeaway upgraded to Neutral from Underperform at Exane BNP Paribas
05/07/21 Bryan Garnier
Just Eat Takeaway.com initiated with a Sell at Bryan Garnier
04/22/21 JPMorgan
Just Eat Takeaway.com downgraded to Neutral from Overweight at JPMorgan
ELY Callaway Golf
$34.51 /

+0.17 (+0.50%)

GRUB GrubHub
$18.80 /

+0.27 (+1.46%)

GRUB GrubHub
$18.80 /

+0.27 (+1.46%)

TKAYY Just Eat Takeaway.com
$10.47 /

+ (+0.00%)

ELY Callaway Golf
$34.51 /

+0.17 (+0.50%)

GRUB GrubHub
$18.80 /

+0.27 (+1.46%)

ELY Callaway Golf
$34.51 /

+0.17 (+0.50%)

Conference/Events
Skylight Health management to meet with Oppenheimer » 04:55
06/15/21
06/15
04:55
06/15/21
04:55
SLHG

Skylight Health

$4.72 /

-0.35 (-6.90%)

Meeting to be held on…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SLHG Skylight Health
$4.72 /

-0.35 (-6.90%)

Conference/Events
Wedbush tech strategist to hold an analyst/industry conference call » 04:55
06/15/21
06/15
04:55
06/15/21
04:55

Chief Technology…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Microsoft participates in a conference call with Benchmark » 04:55
06/15/21
06/15
04:55
06/15/21
04:55
MSFT

Microsoft

$259.95 /

+2.07 (+0.80%)

Entertainment &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MSFT Microsoft
$259.95 /

+2.07 (+0.80%)

MSFT Microsoft
$259.95 /

+2.07 (+0.80%)

06/07/21 Morgan Stanley
Microsoft valuation presents 'attractive entry point,' says Morgan Stanley
06/03/21 Tigress Financial
Microsoft shares going to $303 in 12 months, says Tigress Financial
06/01/21 KGI Securities
Microsoft initiated with an Outperform at KGI Securities
05/27/21 UBS
Zoom Video initiated with a Neutral at UBS
MSFT Microsoft
$259.95 /

+2.07 (+0.80%)

MSFT Microsoft
$259.95 /

+2.07 (+0.80%)

MSFT Microsoft
$259.95 /

+2.07 (+0.80%)

MSFT Microsoft
$259.95 /

+2.07 (+0.80%)

Hot Stocks
Apollo Medical to replace Callaway Golf in the S&P 600 at open on 6/15 » 04:55
06/15/21
06/15
04:55
06/15/21
04:55
AMEH

Apollo Medical

$48.82 /

+0.41 (+0.85%)

, ELY

Callaway Golf

$34.51 /

+0.17 (+0.50%)

Apollo Medical Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMEH Apollo Medical
$48.82 /

+0.41 (+0.85%)

ELY Callaway Golf
$34.51 /

+0.17 (+0.50%)

AMEH Apollo Medical
$48.82 /

+0.41 (+0.85%)

ELY Callaway Golf
$34.51 /

+0.17 (+0.50%)

05/20/21 Roth Capital
Callaway Golf price target raised to $41 from $34 at Roth Capital
05/11/21 B. Riley
Callaway Golf price target raised to $38 from $35 at B. Riley
04/14/21 B. Riley
B. Riley reiterates $35 target on Callaway after Master's tournament
04/07/21 Roth Capital
Callaway Golf price target raised to $34 from $26 at Roth Capital
AMEH Apollo Medical
$48.82 /

+0.41 (+0.85%)

ELY Callaway Golf
$34.51 /

+0.17 (+0.50%)

AMEH Apollo Medical
$48.82 /

+0.41 (+0.85%)

ELY Callaway Golf
$34.51 /

+0.17 (+0.50%)

ELY Callaway Golf
$34.51 /

+0.17 (+0.50%)

Conference/Events
Bunge participates in a conference call with Stephens » 04:55
06/15/21
06/15
04:55
06/15/21
04:55
BG

Bunge

$82.62 /

-2.1 (-2.48%)

Conference call with CEO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BG Bunge
$82.62 /

-2.1 (-2.48%)

BG Bunge
$82.62 /

-2.1 (-2.48%)

05/06/21 Barclays
Bunge price target raised to $100 from $85 at Barclays
05/05/21 Credit Suisse
Bunge price target raised to $95 from $84 at Credit Suisse
04/21/21 BofA
BofA starts Bunge at Neutral with $88 price target
04/21/21 BofA
Bunge initiated with a Neutral at BofA
BG Bunge
$82.62 /

-2.1 (-2.48%)

Conference/Events
CuriosityStream participates in a conference call with Benchmark » 04:55
06/15/21
06/15
04:55
06/15/21
04:55
CURI

CuriosityStream

$14.99 /

-0.05 (-0.33%)

Analyst Kurnos holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CURI CuriosityStream
$14.99 /

-0.05 (-0.33%)

CURI CuriosityStream
$14.99 /

-0.05 (-0.33%)

05/13/21 Barrington
CuriosityStream price target lowered to $14 from $21 at Barrington
04/09/21 DA Davidson
CuriosityStream initiated with a Buy at DA Davidson
04/09/21 DA Davidson
CuriosityStream initiated with a Buy at DA Davidson
04/06/21 BofA
BofA starts CuriosityStream with Buy on unique positioning in secular M&E area
CURI CuriosityStream
$14.99 /

-0.05 (-0.33%)

  • 04
    Feb
CURI CuriosityStream
$14.99 /

-0.05 (-0.33%)

CURI CuriosityStream
$14.99 /

-0.05 (-0.33%)

Conference/Events
European Hematology Association to hold virtual meeting » 04:55
06/15/21
06/15
04:55
06/15/21
04:55
APTO

Aptose Biosciences

$3.71 /

-0.04 (-1.07%)

, MBIO

Mustang Bio

$3.68 /

-0.11 (-2.90%)

, QURE

uniQure

$34.89 /

-1.24 (-3.43%)

, RIGL

Rigel Pharmaceuticals

$4.37 /

+0.35 (+8.71%)

, MGTA

Magenta Therapeutics

$11.33 /

-0.22 (-1.90%)

, MEIP

MEI Pharma

$3.28 /

+0.005 (+0.15%)

, CRIS

Curis

$8.05 /

+0.05 (+0.63%)

, XLRN

Acceleron

$131.02 /

-2.4 (-1.80%)

, EPZM

Epizyme

$8.81 /

+0.305 (+3.59%)

, INCY

Incyte

$82.61 /

+0.03 (+0.04%)

, ORTX

Orchard Therapeutics

$5.04 /

-0.09 (-1.75%)

, TGTX

TG Therapeutics

$38.30 /

+0.49 (+1.30%)

, EQ

Equillium

$6.00 /

-0.12 (-1.96%)

, JAZZ

Jazz Pharmaceuticals

$186.45 /

+0.15 (+0.08%)

, VRTX

Vertex Pharmaceuticals

$194.81 /

+1.78 (+0.92%)

, SGEN

Seagen

$156.25 /

-0.21 (-0.13%)

, IMRA

Imara

$8.70 /

+0.135 (+1.58%)

, GBT

Global Blood Therapeutics

$40.25 /

-0.32 (-0.79%)

, BGNE

BeiGene

$344.52 /

-5.39 (-1.54%)

, APLS

Apellis

$64.90 /

+2.8 (+4.51%)

, AGIO

Agios Pharmaceuticals

$58.20 /

+0.43 (+0.74%)

, FMTX

Forma Therapeutics

$24.22 /

+1.41 (+6.18%)

, KROS

Keros Therapeutics

$53.00 /

+1.64 (+3.19%)

, CYAD

Celyad

$5.41 /

-0.29 (-5.09%)

, ALXN

Alexion

$181.65 /

+0.08 (+0.04%)

EHA 2021 Virtual Congress…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APTO Aptose Biosciences
$3.71 /

-0.04 (-1.07%)

MBIO Mustang Bio
$3.68 /

-0.11 (-2.90%)

QURE uniQure
$34.89 /

-1.24 (-3.43%)

RIGL Rigel Pharmaceuticals
$4.37 /

+0.35 (+8.71%)

MGTA Magenta Therapeutics
$11.33 /

-0.22 (-1.90%)

MEIP MEI Pharma
$3.28 /

+0.005 (+0.15%)

CRIS Curis
$8.05 /

+0.05 (+0.63%)

XLRN Acceleron
$131.02 /

-2.4 (-1.80%)

EPZM Epizyme
$8.81 /

+0.305 (+3.59%)

INCY Incyte
$82.61 /

+0.03 (+0.04%)

ORTX Orchard Therapeutics
$5.04 /

-0.09 (-1.75%)

TGTX TG Therapeutics
$38.30 /

+0.49 (+1.30%)

EQ Equillium
$6.00 /

-0.12 (-1.96%)

JAZZ Jazz Pharmaceuticals
$186.45 /

+0.15 (+0.08%)

VRTX Vertex Pharmaceuticals
$194.81 /

+1.78 (+0.92%)

SGEN Seagen
$156.25 /

-0.21 (-0.13%)

IMRA Imara
$8.70 /

+0.135 (+1.58%)

GBT Global Blood Therapeutics
$40.25 /

-0.32 (-0.79%)

BGNE BeiGene
$344.52 /

-5.39 (-1.54%)

APLS Apellis
$64.90 /

+2.8 (+4.51%)

AGIO Agios Pharmaceuticals
$58.20 /

+0.43 (+0.74%)

FMTX Forma Therapeutics
$24.22 /

+1.41 (+6.18%)

KROS Keros Therapeutics
$53.00 /

+1.64 (+3.19%)

CYAD Celyad
$5.41 /

-0.29 (-5.09%)

ALXN Alexion
$181.65 /

+0.08 (+0.04%)

APTO Aptose Biosciences
$3.71 /

-0.04 (-1.07%)

02/22/21 JonesTrading
Aptose Biosciences resumed with a Buy at JonesTrading
10/19/20 Cantor Fitzgerald
Aptose Biosciences initiated with an Overweight at Cantor Fitzgerald
09/22/20 Alliance Global Partners
Aptose Biosciences initiated with a Buy at Alliance Global Partners
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
MBIO Mustang Bio
$3.68 /

-0.11 (-2.90%)

05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/12/21 Cantor Fitzgerald
Mustang Bio EHA abstract data 'looks promising,' says Cantor Fitzgerald
12/23/20 B. Riley Securities
Mustang Bio transferred with a Buy at B. Riley Securities
QURE uniQure
$34.89 /

-1.24 (-3.43%)

06/14/21 BTIG
uniQure initiated with a Buy at BTIG
05/20/21 UBS
uniQure initiated with a Neutral at UBS
05/19/21 H.C. Wainwright
uniQure price target raised to $90 from $80 at H.C. Wainwright
04/26/21 Chardan
Chardan sees 'stock momentum' for uniQure after clinical hold lift
RIGL Rigel Pharmaceuticals
$4.37 /

+0.35 (+8.71%)

06/11/21 BMO Capital
Rigel Pharmaceuticals coverage transferred at BMO Capital
05/12/21 Cantor Fitzgerald
Rigel rallying on Curis IRAK4 program data, says Cantor Fitzgerald
04/13/21 Piper Sandler
Rigel results in severe COVID-19 trial 'pretty dramatic,' says Piper Sandler
02/18/21 H.C. Wainwright
Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright
MGTA Magenta Therapeutics
$11.33 /

-0.22 (-1.90%)

06/14/21 BTIG
Magenta Therapeutics initiated with a Buy at BTIG
05/18/21 B. Riley
Magenta Therapeutics initiated with a Buy, $21 target at B. Riley
05/17/21 B. Riley
Magenta Therapeutics initiated with a Buy at B. Riley
05/13/21 Mizuho
Magenta Therapeutics price target raised to $17 from $16 at Mizuho
MEIP MEI Pharma
$3.28 /

+0.005 (+0.15%)

04/26/21 Wells Fargo
MEI Pharma likely to expand scope of voruciclib development, says Wells Fargo
10/12/20 Brookline
MEI Pharma initiated with a Buy at Brookline
09/22/20 Alliance Global Partners
MEI Pharma initiated with a Buy at Alliance Global Partners
07/06/20 SunTrust
MEI Pharma price target lowered to $12 from $16 at SunTrust
CRIS Curis
$8.05 /

+0.05 (+0.63%)

05/13/21 B. Riley
Curis price target raised to $22 from $19 at B. Riley
05/13/21 Cantor Fitzgerald
Curis price target raised to $24 from $15 at Cantor Fitzgerald
05/12/21 Cantor Fitzgerald
Rigel rallying on Curis IRAK4 program data, says Cantor Fitzgerald
05/12/21 Cantor Fitzgerald
Initial look from Curis EHA updates 'very positive,' says Cantor Fitzgerald
XLRN Acceleron
$131.02 /

-2.4 (-1.80%)

06/11/21 H.C. Wainwright
Acceleron results for Phase 2 BEYOND study 'impressive,' says H.C. Wainwright
05/19/21 Piper Sandler
Piper remains bullish on Acceleron after Phase 2 PULSAR OLE, SPECTRA updates
04/26/21 Credit Suisse
Acceleron assumed with an Outperform at Credit Suisse
03/23/21
Fly Intel: Top five analyst downgrades
EPZM Epizyme
$8.81 /

+0.305 (+3.59%)

05/07/21 SVB Leerink
Epizyme upgraded to Outperform from Market Perform at SVB Leerink
04/23/21 Cowen
Epizyme transferred with Outperform at Cowen
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
INCY Incyte
$82.61 /

+0.03 (+0.04%)

02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/04/21 Guggenheim
Incyte upgraded to Buy from Neutral at Guggenheim
ORTX Orchard Therapeutics
$5.04 /

-0.09 (-1.75%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/02/21 JPMorgan
Orchard Therapeutics assumed with an Overweight at JPMorgan
03/01/21 Stifel
Orchard Therapeutics initiated with a Buy at Stifel
02/18/21 Goldman Sachs
Orchard selloff on Bluebird Bio news overdone, says Goldman Sachs
TGTX TG Therapeutics
$38.30 /

+0.49 (+1.30%)

04/20/21
Fly Intel: Top five analyst initiations
04/20/21 Goldman Sachs
TG Therapeutics initiated with a Neutral at Goldman Sachs
04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
EQ Equillium
$6.00 /

-0.12 (-1.96%)

03/03/21
Fly Intel: Top five analyst initiations
03/03/21 JonesTrading
Equillium initiated with a Buy at JonesTrading
11/30/20 H.C. Wainwright
Equillium price target lowered to $12 from $22 at H.C. Wainwright
07/14/20 H.C. Wainwright
Equillium price target raised to $24 from $14 at H.C. Wainwright
JAZZ Jazz Pharmaceuticals
$186.45 /

+0.15 (+0.08%)

05/19/21
Fly Intel: Top five analyst initiations
05/19/21 JPMorgan
Jazz Pharmaceuticals resumed with an Overweight at JPMorgan
05/17/21 H.C. Wainwright
Jazz Pharmaceuticals price target raised to $212 from $207 at H.C. Wainwright
04/21/21 Cantor Fitzgerald
Jazz Pharmaceuticals price target raised to $198 from $185 at Cantor Fitzgerald
VRTX Vertex Pharmaceuticals
$194.81 /

+1.78 (+0.92%)

06/14/21 Truist
Vertex Pharmaceuticals price target raised to $331 from $305 at Truist
06/14/21 SVB Leerink
Vertex Pharmaceuticals price target lowered to $200 from $250 at SVB Leerink
06/14/21 Deutsche Bank
Grifols upgraded to Buy from Hold at Deutsche Bank
06/13/21 Piper Sandler
Vertex Pharmaceuticals price target lowered to $261 from $347 at Piper Sandler
SGEN Seagen
$156.25 /

-0.21 (-0.13%)

05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/30/21 Credit Suisse
Seagen initiated with a Neutral at Credit Suisse
IMRA Imara
$8.70 /

+0.135 (+1.58%)

03/08/21 SVB Leerink
Imara price target lowered to $42 from $59 at SVB Leerink
01/06/21 SVB Leerink
Imara selloff a potential buying opportunity, says SVB Leerink
08/17/20
Fly Intel: Top five analyst upgrades
08/17/20 Citi
Imara upgraded to Buy from Neutral at Citi
GBT Global Blood Therapeutics
$40.25 /

-0.32 (-0.79%)

05/07/21 Cantor Fitzgerald
Global Blood Therapeutics price target lowered to $110 from $120 at Cantor Fitzgerald
05/06/21 Piper Sandler
Global Blood price target lowered to $45 from $50 at Piper Sandler
04/14/21
Fly Intel: Top five analyst initiations
04/14/21 SVB Leerink
SVB Leerink bullish on Global Blood Therapeutics, initiates with an Outperform
BGNE BeiGene
$344.52 /

-5.39 (-1.54%)

06/14/21 SVB Leerink
BeiGene price target raised to $417 from $388 at SVB Leerink
03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
APLS Apellis
$64.90 /

+2.8 (+4.51%)

05/20/21 UBS
Apellis initiated with a Buy at UBS
05/18/21 BMO Capital
Apellis price target raised to $68 from $64 at BMO Capital
05/17/21 Oppenheimer
Apellis price target raised to $67 from $64 at Oppenheimer
05/17/21 Raymond James
Apellis price target raised to $115 from $104 at Raymond James
AGIO Agios Pharmaceuticals
$58.20 /

+0.43 (+0.74%)

06/10/21 H.C. Wainwright
Agios Pharmaceuticals initiated with a Buy at H.C. Wainwright
04/30/21 Goldman Sachs
Agios Pharmaceuticals reinstated with a Neutral at Goldman Sachs
04/30/21 Barclays
Agios Pharmaceuticals price target raised to $70 from $65 at Barclays
03/30/21 Piper Sandler
Agios should rally on Forma Therapeutics data, says Piper Sandler
FMTX Forma Therapeutics
$24.22 /

+1.41 (+6.18%)

03/31/21 H.C. Wainwright
Forma Therapeutics price target raised to $55 from $53 at H.C. Wainwright
03/30/21 Piper Sandler
Agios should rally on Forma Therapeutics data, says Piper Sandler
02/17/21
Fly Intel: Top five analyst initiations
02/17/21 Oppenheimer
Forma Therapeutics initiated with an Outperform at Oppenheimer
KROS Keros Therapeutics
$53.00 /

+1.64 (+3.19%)

12/08/20 SVB Leerink
Keros Therapeutics price target raised to $80 from $42 at SVB Leerink
12/08/20 H.C. Wainwright
Keros Therapeutics price target raised to $100 from $50 at H.C. Wainwright
12/08/20 Piper Sandler
Keros Therapeutics price target raised to $95 from $75 at Piper Sandler
11/18/20 Piper Sandler
Keros Therapeutics price target raised to $75 from $55 at Piper Sandler
CYAD Celyad
$5.41 /

-0.29 (-5.09%)

03/25/21 JonesTrading
Celyad downgraded to Hold from Buy at JonesTrading
12/08/20 H.C. Wainwright
Celyad price target lowered to $18 from $22 at H.C. Wainwright
ALXN Alexion
$181.65 /

+0.08 (+0.04%)

05/05/21
Fly Intel: Top five analyst upgrades
05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
05/03/21 SVB Leerink
Alexion price target raised to $173 from $156 at SVB Leerink
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
APTO Aptose Biosciences
$3.71 /

-0.04 (-1.07%)

MBIO Mustang Bio
$3.68 /

-0.11 (-2.90%)

QURE uniQure
$34.89 /

-1.24 (-3.43%)

RIGL Rigel Pharmaceuticals
$4.37 /

+0.35 (+8.71%)

MGTA Magenta Therapeutics
$11.33 /

-0.22 (-1.90%)

MEIP MEI Pharma
$3.28 /

+0.005 (+0.15%)

CRIS Curis
$8.05 /

+0.05 (+0.63%)

XLRN Acceleron
$131.02 /

-2.4 (-1.80%)

EPZM Epizyme
$8.81 /

+0.305 (+3.59%)

INCY Incyte
$82.61 /

+0.03 (+0.04%)

ORTX Orchard Therapeutics
$5.04 /

-0.09 (-1.75%)

TGTX TG Therapeutics
$38.30 /

+0.49 (+1.30%)

EQ Equillium
$6.00 /

-0.12 (-1.96%)

JAZZ Jazz Pharmaceuticals
$186.45 /

+0.15 (+0.08%)

VRTX Vertex Pharmaceuticals
$194.81 /

+1.78 (+0.92%)

SGEN Seagen
$156.25 /

-0.21 (-0.13%)

IMRA Imara
$8.70 /

+0.135 (+1.58%)

GBT Global Blood Therapeutics
$40.25 /

-0.32 (-0.79%)

BGNE BeiGene
$344.52 /

-5.39 (-1.54%)

APLS Apellis
$64.90 /

+2.8 (+4.51%)

AGIO Agios Pharmaceuticals
$58.20 /

+0.43 (+0.74%)

FMTX Forma Therapeutics
$24.22 /

+1.41 (+6.18%)

KROS Keros Therapeutics
$53.00 /

+1.64 (+3.19%)

ALXN Alexion
$181.65 /

+0.08 (+0.04%)

  • 15
    Dec
  • 11
    Dec
  • 09
    Dec
  • 02
    Dec
  • 13
    Nov
  • 14
    Aug
  • 16
    Jul
  • 01
    Jul
  • 25
    Jun
  • 19
    Jun
RIGL Rigel Pharmaceuticals
$4.37 /

+0.35 (+8.71%)

EPZM Epizyme
$8.81 /

+0.305 (+3.59%)

INCY Incyte
$82.61 /

+0.03 (+0.04%)

ORTX Orchard Therapeutics
$5.04 /

-0.09 (-1.75%)

JAZZ Jazz Pharmaceuticals
$186.45 /

+0.15 (+0.08%)

VRTX Vertex Pharmaceuticals
$194.81 /

+1.78 (+0.92%)

APTO Aptose Biosciences
$3.71 /

-0.04 (-1.07%)

MBIO Mustang Bio
$3.68 /

-0.11 (-2.90%)

QURE uniQure
$34.89 /

-1.24 (-3.43%)

CRIS Curis
$8.05 /

+0.05 (+0.63%)

INCY Incyte
$82.61 /

+0.03 (+0.04%)

TGTX TG Therapeutics
$38.30 /

+0.49 (+1.30%)

EQ Equillium
$6.00 /

-0.12 (-1.96%)

JAZZ Jazz Pharmaceuticals
$186.45 /

+0.15 (+0.08%)

VRTX Vertex Pharmaceuticals
$194.81 /

+1.78 (+0.92%)

SGEN Seagen
$156.25 /

-0.21 (-0.13%)

IMRA Imara
$8.70 /

+0.135 (+1.58%)

GBT Global Blood Therapeutics
$40.25 /

-0.32 (-0.79%)

APLS Apellis
$64.90 /

+2.8 (+4.51%)

ALXN Alexion
$181.65 /

+0.08 (+0.04%)

CRIS Curis
$8.05 /

+0.05 (+0.63%)

INCY Incyte
$82.61 /

+0.03 (+0.04%)

EQ Equillium
$6.00 /

-0.12 (-1.96%)

VRTX Vertex Pharmaceuticals
$194.81 /

+1.78 (+0.92%)

APLS Apellis
$64.90 /

+2.8 (+4.51%)

FMTX Forma Therapeutics
$24.22 /

+1.41 (+6.18%)

ALXN Alexion
$181.65 /

+0.08 (+0.04%)

Conference/Events
Clearfield management to meet virtually with Lake Street » 04:55
06/15/21
06/15
04:55
06/15/21
04:55
CLFD

Clearfield

$36.47 /

-5.44 (-12.98%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLFD Clearfield
$36.47 /

-5.44 (-12.98%)

04/23/21
Fly Intel: Top five analyst upgrades
04/23/21 Northland
Clearfield upgraded to Outperform from Market Perform at Northland
01/29/21 Lake Street
Clearfield price target raised to $37 from $25 at Lake Street
01/29/21 Northland
Clearfield downgraded to Market Perform from Outperform at Northland
CLFD Clearfield
$36.47 /

-5.44 (-12.98%)

Conference/Events
Gain Therapeutics management to meet virtually with Oppenheimer » 04:55
06/15/21
06/15
04:55
06/15/21
04:55
GANX

Gain Therapeutics

$9.79 /

-0.34 (-3.36%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GANX Gain Therapeutics
$9.79 /

-0.34 (-3.36%)

GANX Gain Therapeutics
$9.79 /

-0.34 (-3.36%)

04/12/21 Oppenheimer
Gain Therapeutics initiated with an Outperform at Oppenheimer
04/12/21 Oppenheimer
Gain Therapeutics initiated with an Outperform at Oppenheimer
04/12/21 BTIG
Gain Therapeutics initiated with a Buy at BTIG
  • 18
    Mar
GANX Gain Therapeutics
$9.79 /

-0.34 (-3.36%)

Conference/Events
Kaleyra participates in a conference call with Maxim » 04:55
06/15/21
06/15
04:55
06/15/21
04:55
KLR

Kaleyra

$11.76 /

-0.64 (-5.16%)

Conference call with CEO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KLR Kaleyra
$11.76 /

-0.64 (-5.16%)

KLR Kaleyra
$11.76 /

-0.64 (-5.16%)

06/11/21 Northland
Kaleyra price target raised to $29 from $23 at Northland
03/19/21 Northland
Kaleyra on track for 21% growth in Q1, says Northland
02/22/21 Maxim
Kaleyra price target raised to $42 from $30 at Maxim
02/17/21 Craig-Hallum
Kaleyra price target raised to $25 from $20 at Craig-Hallum
KLR Kaleyra
$11.76 /

-0.64 (-5.16%)

  • 25
    Jun
KLR Kaleyra
$11.76 /

-0.64 (-5.16%)

KLR Kaleyra
$11.76 /

-0.64 (-5.16%)

Conference/Events
JD.com participates in a conference call with Benchmark » 04:55
06/15/21
06/15
04:55
06/15/21
04:55
JD

JD.com

$71.43 /

+0.21 (+0.29%)

Analyst Jiang holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JD JD.com
$71.43 /

+0.21 (+0.29%)

JD JD.com
$71.43 /

+0.21 (+0.29%)

06/01/21 Spin-Off Research
JD.com initiated with a Buy at Spin-Off Research
05/21/21 Susquehanna
JD.com price target lowered to $80 from $90 at Susquehanna
05/20/21 Benchmark
JD.com price target lowered to $112 from $122 at Benchmark
05/20/21 HSBC
JD.com price target lowered to $89 from $98 at HSBC
JD JD.com
$71.43 /

+0.21 (+0.29%)

JD JD.com
$71.43 /

+0.21 (+0.29%)

JD JD.com
$71.43 /

+0.21 (+0.29%)

JD JD.com
$71.43 /

+0.21 (+0.29%)

Conference/Events
Whitestone REIT management to meet virtually with BTIG » 04:55
06/15/21
06/15
04:55
06/15/21
04:55
WSR

Whitestone REIT

$8.67 /

+ (+0.00%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WSR Whitestone REIT
$8.67 /

+ (+0.00%)

WSR Whitestone REIT
$8.67 /

+ (+0.00%)

12/30/20 JMP Securities
Whitestone traffic outperforming shopping center peers, says JMP Securities
WSR Whitestone REIT
$8.67 /

+ (+0.00%)

Conference/Events
BioVie management to meet virtually with B. Riley » 04:55
06/15/21
06/15
04:55
06/15/21
04:55
BIVI

BioVie

$18.01 /

+0.06 (+0.33%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BIVI BioVie
$18.01 /

+0.06 (+0.33%)

BIVI BioVie
$18.01 /

+0.06 (+0.33%)

05/25/21 B. Riley
BioVie price target raised to $50 from $47 at B. Riley
01/15/21 B. Riley Securities
B. Riley starts 'largely overlooked' BioVie with Buy, $47 target
01/15/21 B. Riley Securities
BioVie initiated with a Buy at B. Riley Securities
Conference/Events
Carlisle management to meet virtually with Oppenheimer » 04:55
06/15/21
06/15
04:55
06/15/21
04:55
CSL

Carlisle

$187.56 /

-1.995 (-1.05%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CSL Carlisle
$187.56 /

-1.995 (-1.05%)

CSL Carlisle
$187.56 /

-1.995 (-1.05%)

05/14/21 Oppenheimer
Carlisle price target raised to $210 from $194 at Oppenheimer
04/26/21 Loop Capital
Carlisle price target raised to $205 from $184 at Loop Capital
04/26/21 BMO Capital
Carlisle price target raised to $225 from $180 at BMO Capital
04/16/21 Jefferies
Carlisle price increases point to strong demand, says Jefferies
CSL Carlisle
$187.56 /

-1.995 (-1.05%)

Conference/Events
MoffettNathanson eCommerce analysts to hold analyst/industry conference call » 04:55
06/15/21
06/15
04:55
06/15/21
04:55
V

Visa

$234.08 /

-0.8 (-0.34%)

, MA

MasterCard

$366.54 /

+1.05 (+0.29%)

, AXP

American Express

$163.80 /

-0.74 (-0.45%)

, PYPL

PayPal

$274.95 /

+3.47 (+1.28%)

, FIS

FIS

$146.51 /

+0.86 (+0.59%)

, FISV

Fiserv

$109.04 /

-1.1 (-1.00%)

, GPN

Global Payments

$192.17 /

-1.31 (-0.68%)

, SQ

Square

$231.01 /

+11.655 (+5.31%)

eCommerce Analysts and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
V Visa
$234.08 /

-0.8 (-0.34%)

MA MasterCard
$366.54 /

+1.05 (+0.29%)

AXP American Express
$163.80 /

-0.74 (-0.45%)

PYPL PayPal
$274.95 /

+3.47 (+1.28%)

FIS FIS
$146.51 /

+0.86 (+0.59%)

FISV Fiserv
$109.04 /

-1.1 (-1.00%)

GPN Global Payments
$192.17 /

-1.31 (-0.68%)

SQ Square
$231.01 /

+11.655 (+5.31%)

V Visa
$234.08 /

-0.8 (-0.34%)

06/08/21 Credit Suisse
Visa price target raised to $285 from $280 at Credit Suisse
06/07/21
Fly Intel: Top five analyst upgrades
06/07/21 Barclays
Visa price target raised to $284 from $275 at Barclays
06/07/21 Piper Sandler
Visa upgraded to Overweight from Neutral at Piper Sandler
MA MasterCard
$366.54 /

+1.05 (+0.29%)

06/07/21 Barclays
MasterCard price target raised to $452 from $440 at Barclays
06/07/21 Piper Sandler
Visa upgraded to Overweight from Neutral at Piper Sandler
05/18/21 Daiwa
MasterCard upgraded to Outperform from Neutral at Daiwa
05/05/21 Credit Suisse
Global Payments price target raised to $225 from $220 at Credit Suisse
AXP American Express
$163.80 /

-0.74 (-0.45%)

06/07/21 Wells Fargo
American Express price target raised to $185 from $165 at Wells Fargo
06/04/21 Wolfe Research
Wolfe calls American Express 'table-pounding buy,' makes target Street-high
04/26/21 MoffettNathanson
American Express a strong pandemic recovery play, says MoffettNathanson
04/26/21 Oppenheimer
American Express price target raised to $165 from $128 at Oppenheimer
PYPL PayPal
$274.95 /

+3.47 (+1.28%)

05/07/21 BMO Capital
PayPal price target raised to $256 from $241 at BMO Capital
05/07/21 Oppenheimer
PayPal price target raised to $322 from $310 at Oppenheimer
05/06/21 Oppenheimer
PayPal price target raised to $322 from $310 at Oppenheimer
05/06/21 Credit Suisse
PayPal price target raised to $315 from $310 at Credit Suisse
FIS FIS
$146.51 /

+0.86 (+0.59%)

06/07/21
Fly Intel: Top five analyst downgrades
06/07/21 Truist
FIS downgraded to Hold from Buy at Truist
06/07/21 Truist
FIS downgraded to Hold from Buy at Truist
05/13/21 Jefferies
Global Payments selloff presents attractive entry point, says Jefferies
FISV Fiserv
$109.04 /

-1.1 (-1.00%)

06/07/21 Truist
Fiserv downgraded to Hold from Buy at Truist
06/07/21 Truist
Fiserv downgraded to Hold from Buy at Truist
05/05/21 Credit Suisse
Global Payments price target raised to $225 from $220 at Credit Suisse
04/28/21 Truist
Fiserv price target raised to $135 from $120 at Truist
GPN Global Payments
$192.17 /

-1.31 (-0.68%)

05/13/21 Jefferies
Global Payments selloff presents attractive entry point, says Jefferies
05/05/21 Credit Suisse
Global Payments price target raised to $225 from $220 at Credit Suisse
05/05/21 Oppenheimer
Global Payments price target raised to $231 from $222 at Oppenheimer
04/27/21 Deutsche Bank
Global Payments price target raised to $235 from $207 at Deutsche Bank
SQ Square
$231.01 /

+11.655 (+5.31%)

05/25/21 Baird
Square comps starting to get more difficult, says Baird
05/20/21 Tigress Financial
Square shares have close to 50% upside potential, says Tigress Financial
05/10/21 BMO Capital
Square price target raised to $269 from $237 at BMO Capital
05/07/21 JPMorgan
Square price target raised to $300 from $250 at JPMorgan
V Visa
$234.08 /

-0.8 (-0.34%)

MA MasterCard
$366.54 /

+1.05 (+0.29%)

AXP American Express
$163.80 /

-0.74 (-0.45%)

PYPL PayPal
$274.95 /

+3.47 (+1.28%)

FIS FIS
$146.51 /

+0.86 (+0.59%)

FISV Fiserv
$109.04 /

-1.1 (-1.00%)

GPN Global Payments
$192.17 /

-1.31 (-0.68%)

SQ Square
$231.01 /

+11.655 (+5.31%)

  • 30
    Apr
  • 10
    Dec
  • 13
    Oct
V Visa
$234.08 /

-0.8 (-0.34%)

MA MasterCard
$366.54 /

+1.05 (+0.29%)

AXP American Express
$163.80 /

-0.74 (-0.45%)

PYPL PayPal
$274.95 /

+3.47 (+1.28%)

FIS FIS
$146.51 /

+0.86 (+0.59%)

GPN Global Payments
$192.17 /

-1.31 (-0.68%)

SQ Square
$231.01 /

+11.655 (+5.31%)

V Visa
$234.08 /

-0.8 (-0.34%)

MA MasterCard
$366.54 /

+1.05 (+0.29%)

AXP American Express
$163.80 /

-0.74 (-0.45%)

PYPL PayPal
$274.95 /

+3.47 (+1.28%)

FIS FIS
$146.51 /

+0.86 (+0.59%)

FISV Fiserv
$109.04 /

-1.1 (-1.00%)

GPN Global Payments
$192.17 /

-1.31 (-0.68%)

SQ Square
$231.01 /

+11.655 (+5.31%)

V Visa
$234.08 /

-0.8 (-0.34%)

MA MasterCard
$366.54 /

+1.05 (+0.29%)

AXP American Express
$163.80 /

-0.74 (-0.45%)

PYPL PayPal
$274.95 /

+3.47 (+1.28%)

FIS FIS
$146.51 /

+0.86 (+0.59%)

FISV Fiserv
$109.04 /

-1.1 (-1.00%)

GPN Global Payments
$192.17 /

-1.31 (-0.68%)

SQ Square
$231.01 /

+11.655 (+5.31%)

Downgrade
Anglo American downgraded to Sector Perform from Outperform at RBC Capital » 04:54
06/15/21
06/15
04:54
06/15/21
04:54
NGLOY

Anglo American

$22.17 /

-0.62 (-2.72%)

RBC Capital analyst Tyler…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NGLOY Anglo American
$22.17 /

-0.62 (-2.72%)

06/07/21 JPMorgan
Anglo American price target raised to 3,500 GBp from 3,350 GBp at JPMorgan
05/19/21 Credit Suisse
Anglo American assumed with an Outperform at Credit Suisse
05/18/21 JPMorgan
Anglo American price target lowered to 3,350 GBp from 3,400 GBp at JPMorgan
05/18/21 Morgan Stanley
Anglo American resumed with an Overweight at Morgan Stanley
NGLOY Anglo American
$22.17 /

-0.62 (-2.72%)

Recommendations
Coca-Cola price target raised to $62 from $60 at Credit Suisse » 04:51
06/15/21
06/15
04:51
06/15/21
04:51
KO

Coca-Cola

$55.54 /

-0.21 (-0.38%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KO Coca-Cola
$55.54 /

-0.21 (-0.38%)

KO Coca-Cola
$55.54 /

-0.21 (-0.38%)

06/04/21 Morgan Stanley
Coca-Cola price target raised to $64 from $60 at Morgan Stanley
05/14/21 Wells Fargo
Wells says Coca-Cola Energy discontinuation may 'rekindle' Monster M&A debate
05/14/21 Evercore ISI
Coke Energy discontinuation a 'small positive' for Monster, says Evercore ISI
04/20/21 Evercore ISI
Evercore raises Coca-Cola price target to $63, sees 'best' outlook 'in years'
KO Coca-Cola
$55.54 /

-0.21 (-0.38%)

KO Coca-Cola
$55.54 /

-0.21 (-0.38%)

KO Coca-Cola
$55.54 /

-0.21 (-0.38%)

KO Coca-Cola
$55.54 /

-0.21 (-0.38%)

Initiation
Coca-Cola Europacific Partners reinstated with an Outperform at Credit Suisse » 04:50
06/15/21
06/15
04:50
06/15/21
04:50
CCEP

Coca-Cola Europacific Partners

$61.67 /

-0.31 (-0.50%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CCEP Coca-Cola Europacific Partners
$61.67 /

-0.31 (-0.50%)

CCEP Coca-Cola Europacific Partners
$61.67 /

-0.31 (-0.50%)

06/02/21 JPMorgan
JPMorgan upgrades Coca-Cola Europacific Partners on reopening momentum
06/01/21 JPMorgan
Coca-Cola European Partners upgraded to Overweight from Neutral at JPMorgan
05/27/21 Argus
Coca-Cola European Partners upgraded to Buy from Hold at Argus
05/27/21 Argus
Coca-Cola European Partners upgraded to Buy from Hold at Argus
Initiation
Aclaris Therapeutics initiated with an Overweight at Piper Sandler » 04:47
06/15/21
06/15
04:47
06/15/21
04:47
ACRS

Aclaris Therapeutics

$17.75 /

-0.62 (-3.38%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACRS Aclaris Therapeutics
$17.75 /

-0.62 (-3.38%)

ACRS Aclaris Therapeutics
$17.75 /

-0.62 (-3.38%)

04/21/21 H.C. Wainwright
Aclaris Therapeutics initiated with a Buy at H.C. Wainwright
03/04/21 SVB Leerink
Aclaris Therapeutics price target raised to $26 from $21 at SVB Leerink
02/02/21 Cantor Fitzgerald
Aclaris Therapeutics price target raised to $30 from $15 at Cantor Fitzgerald
01/19/21 William Blair
Aclaris has potential in range of 'blockbuster indications,' says William Blair
ACRS Aclaris Therapeutics
$17.75 /

-0.62 (-3.38%)

  • 10
    Jun
  • 20
    Jan
ACRS Aclaris Therapeutics
$17.75 /

-0.62 (-3.38%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.